BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 8:26:32 AM | Browse: 381 | Download: 1135
 |
Received |
|
2023-05-29 14:59 |
|
Peer-Review Started |
|
2023-05-29 15:01 |
|
First Decision by Editorial Office Director |
|
2023-06-19 07:25 |
|
Return for Revision |
|
2023-06-19 07:25 |
|
Revised |
|
2023-07-13 12:31 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-07-28 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-28 07:33 |
|
Articles in Press |
|
2023-07-28 07:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-17 05:52 |
|
Publish the Manuscript Online |
|
2023-08-25 08:26 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anwar Khedr, Hussam Al Hennawi, Muhammed Khuzzaim Khan, Aalaa Eissa, Mikael Mir, Ibtisam Rauf, Jain Nitesh, Salim Surani and Syed Anjum Khan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, FCCP, MD, MHSc, Academic Editor, Professor, Department of Medicine & Pharmacology, Texas A&M University, 400 Bizzell St, College Station, TX 77843, United States. srsurani@hotmail.com |
| Key Words |
Sodium-glucose transporter 2 inhibitors; COVID-19; SARS-CoV-2; Diabetic ketoacidosis; Euglycemic diabetic ketoacidosis; Diabetes mellitus |
| Core Tip |
This systematic review provides a comprehensive analysis of the relationship between sodium-glucose cotransporter-2 (SGLT2) inhibitors, euglycemic diabetic ketoacidosis (eu-DKA), and coronavirus disease 2019 (COVID-19) in patients with diabetes. Despite maintaining optimal glycemic control, individuals using SGLT2 inhibitors are still susceptible to both drug-induced and unrelated diabetic ketoacidosis (DKA), with potential adverse consequences during COVID-19 infection. Clinicians should exercise caution when prescribing SGLT2 inhibitors to diabetic patients affected by COVID-19 and carefully consider alternative treatment strategies. A thorough understanding of the intricate interplay between SGLT2 inhibitors, euglycemic DKA, and COVID-19 is crucial for optimizing patient management and achieving favorable clinical outcomes. |
| Publish Date |
2023-08-25 08:26 |
| Citation |
Khedr A, Hennawi HA, Khan MK, Eissa A, Mir M, Rauf I, Nitesh J, Surani S, Khan SA. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports. World J Clin Cases 2023; 11(24): 5700-5709 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i24/5700.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i24.5700 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
